# SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

> **NCT02279498** · PHASE3 · COMPLETED · sponsor: **Anthera Pharmaceuticals** · enrollment: 128 (actual)

## Conditions studied

- Exocrine Pancreatic Insufficiency
- Cystic Fibrosis

## Interventions

- **DRUG:** Liprotamase
- **DRUG:** porcine (pig) PERT

## Key facts

- **NCT ID:** NCT02279498
- **Lead sponsor:** Anthera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-10
- **Final completion:** 2017-01-20
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2018-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279498, "SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02279498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*